- $3.01bn
- $3.03bn
- $88.33m
Annual income statement for AXT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 137 | 141 | 75.8 | 99.4 | 88.3 |
| Cost of Revenue | |||||
| Gross Profit | 47.4 | 52.1 | 13.3 | 23.8 | 11.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 124 | 129 | 97.4 | 114 | 110 |
| Operating Profit | 12.9 | 12.6 | -21.6 | -14.8 | -22 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 17.6 | 20.9 | -19 | -10.7 | -21.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 16.5 | 18.7 | -19.2 | -11.8 | -23.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 14.6 | 15.8 | -17.9 | -11.6 | -21.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 14.4 | 15.6 | -18.1 | -11.8 | -21.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.337 | 0.366 | -0.423 | -0.273 | -0.488 |